本页面由Tiger Trade Technology Pte. Ltd.提供服务

Agios Pharmaceuticals, Inc.

35.20
+1.012.95%
盘后35.200.00000.00%19:57 EDT
成交量:142.55万
成交额:4,985.74万
市值:20.53亿
市盈率:-4.94
高:35.35
开:33.97
低:33.52
收:34.19
52周最高:46.00
52周最低:22.24
股本:5,831.38万
流通股本:5,134.85万
量比:0.90
换手率:2.78%
股息:- -
股息率:- -
每股收益(TTM):-7.1203
每股收益(LYR):-7.1203
净资产收益率:-30.20%
总资产收益率:-19.94%
市净率:1.72
市盈率(LYR):-4.94

数据加载中...

2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/10/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/04

重要事件披露

Form 8-K - Current report
2025/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/31

重要事件披露

Form 8-K - Current report
2025/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/08

重要事件披露

Form 8-K - Current report
2025/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities